Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study)

Related Experiment Videos

Matteo Cesari1, Brenda W J H Penninx, Anne B Newman

  • 1Sticht Center on Aging, Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157, USA. mcesari@wfubmc.edu

Insights

Elevated levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) are linked to increased risks of subclinical and clinical cardiovascular disease in older adults. C-reactive protein (CRP) showed a weaker association overall but was linked to congestive heart failure.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Immunology
  • Biomarkers

Background:

  • Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality in aging populations.
  • Inflammatory processes are increasingly recognized as key contributors to the development of atherosclerosis and CVD.
  • Specific inflammatory markers, including cytokines and their soluble receptors, may serve as indicators of CVD risk.

Purpose of the Study:

  • To investigate the association between serum levels of key inflammatory markers and subclinical or clinical cardiovascular disease in older adults.
  • To compare the predictive value of interleukin-6 (IL-6), C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-alpha), and their soluble receptors for CVD.

Main Methods:

  • Cross-sectional analysis of 3,045 well-functioning individuals aged 70-79 years from the Health, Aging and Body Composition study.
  • Participants categorized into 'cardiovascular disease', 'subclinical cardiovascular disease', or 'no cardiovascular disease' groups.
  • Serum levels of IL-6, CRP, TNF-alpha, and soluble cytokine receptors were measured and statistically analyzed for associations.

Main Results:

  • Higher levels of IL-6 and TNF-alpha were significantly associated with increased odds of both subclinical and clinical cardiovascular disease.
  • C-reactive protein (CRP) showed no significant association with overall subclinical or clinical CVD, but was linked to congestive heart failure.
  • Tumor necrosis factor soluble receptor I was the only soluble receptor significantly associated with clinical cardiovascular disease.

Conclusions:

  • Interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) play a significant role in both subclinical and clinical cardiovascular disease in older adults.
  • CRP demonstrated a weaker association with overall CVD compared to IL-6 and TNF-alpha in this cohort.
  • These findings highlight the importance of specific inflammatory cytokines as potential biomarkers for cardiovascular risk assessment in the elderly.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Inflammation01:38

Inflammation

Overview
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...